Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 87-1841713 · Snapshot of IRS recognition, filing currency, financial health, and governance.
Retpositive advances research on RET-positive oncogenedriven cancers to improve patient outcomes and quality of life. 1 Research Grant Funding LUNGevity collaboration. Provided a competitive grant to support biomedical research focused on RET-positive oncogenes accelerating discovery and potential clinical impact for patients with RET-driven disease. 2 Public Awareness & Education informational video. Produced and distributed an educational video highlighting the challenges faced by RET-positive patients and their caregivers improving awareness among patients families and clinicians. 3 Patient Community & Information Access Retpositive.org + moderated support group. Maintained Retpositive.org with up-to-date resources and moderated a private volunteer-run peer-support community to connect patients and caregivers with timely information and shared experience.
Total Revenue
$159K
FY2024
Total Expenses
$76K
FY2024
Net Assets
$164K
Program Ratio
46.0%
expenses on programs
Employees
—
Volunteers
—
Board Members
—
Voting
—
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.